Wall Street may be past the worst of the tariff headlines two weeks after the initial April 2 announcement — as President Donald Trump endeavors to accomplish enormous trade deals during his 90-day pause — but volatility will continue to be a mainstay of the stock market for the foreseeable future. Investors wrapped up yet…
Defense stocks are proving to be a rare source of outperformance as worries over tariffs derailing the economy ramp up. Markets were taken for a wild ride this week as President Donald Trump ratches up trade tensions with other countries. On Thursday, the S & P 500 fell 3.5% — after skyrocketing 9% on Wednesday…
The Magnificent Seven companies reporting in the week ahead could unlock the next leg of the rally, as investors bet that earnings growth fueled by artificial intelligence could power a market some worry has gone to excess. The Federal Reserve will also hold its January meeting, with key inflation data coming Friday. Four out of…
Traders work on the floor of the New York Stock Exchange on Oct. 22, 2024. Spencer Platt | Getty Images S&P 500 futures are muted Thursday night after the broad index ended a three-day negative streak. Futures tied to the broad index added less than 0.1%, as did Nasdaq 100 futures. Dow Jones Industrial Average…
(This is CNBC Pro’s live coverage of Thursday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to view the latest posts.) A pharmacy operator and an industrial stock were among the stocks being talked by analysts on Thursday. Barclays upgraded CVS to overweight from equal weight, calling for 24% upside. Meanwhile, JPMorgan…
Stocks ranging from L3Harris to Burlington could benefit from either a Trump or Harris victory this fall, according to Barclays. “In addition to the general unpredictability of U.S. politics, this election in particular is being closely watched given the divergent economic policies, depending on the results,” analyst Terence Malone said in a Wednesday note. “With…